Literature DB >> 12636163

The effect of CTAB concentration in cationic PLG microparticles on DNA adsorption and in vivo performance.

Manmohan Singh1, Mildred Ugozzoli, Maylene Briones, Jina Kazzaz, Elawati Soenawan, Derek T O'Hagan.   

Abstract

PURPOSE: Cationic PLG microparticles with adsorbed DNA have previously been shown to efficiently target antigen presenting cells in vivo for generating higher immune responses in comparison to naked DNA. In this study we tried to establish the role of surfactant (CTAB) concentration on the physical behavior of these formulations.
METHODS: Cationic PLG microparticle formulations with adsorbed DNA were prepared using a solvent evaporation technique. Formulations with varying CTAB concentrations and a fixed DNA load were prepared. The loading efficiency and 24 h DNA release was evaluated for each formulation. Select formulations were tested in vivo.
RESULTS: Higher CTAB concentration correlated with higher DNA binding efficiency on the microparticles and lower in vitro release rates. Surprisingly though, the in vivo performance of formulations with varying CTAB concentration was comparable to one another.
CONCLUSIONS: Cationic PLG microparticles with adsorbed DNA, as described here, offer a robust way of enhancing in vivo responses to plasmid DNA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12636163     DOI: 10.1023/a:1022327305369

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics.

Authors:  E Walter; K Moelling; J Pavlovic; H P Merkle
Journal:  J Control Release       Date:  1999-09-20       Impact factor: 9.776

Review 2.  DNA vaccines: immunology, application, and optimization*.

Authors:  S Gurunathan; D M Klinman; R A Seder
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery.

Authors:  M Briones; M Singh; M Ugozzoli; J Kazzaz; S Klakamp; G Ott; D O'Hagan
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

Review 4.  Therapeutic ultrasound: its application in drug delivery.

Authors:  Ka-yun Ng; Yang Liu
Journal:  Med Res Rev       Date:  2002-03       Impact factor: 12.944

5.  Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA.

Authors:  Y Capan; B H Woo; S Gebrekidan; S Ahmed; P P DeLuca
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

6.  Nanoparticle DNA carrier with poly(L-lysine) grafted polysaccharide copolymer and poly(D,L-lactic acid).

Authors:  A Maruyama; T Ishihara; J S Kim; S W Kim; T Akaike
Journal:  Bioconjug Chem       Date:  1997 Sep-Oct       Impact factor: 4.774

7.  Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses.

Authors:  M L Hedley; J Curley; R Urban
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

Review 8.  DNA vaccines.

Authors:  J J Donnelly; J B Ulmer; M A Liu
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

9.  DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines.

Authors:  J Rice; T Elliott; S Buchan; F K Stevenson
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

10.  Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines.

Authors:  D O'Hagan; M Singh; M Ugozzoli; C Wild; S Barnett; M Chen; M Schaefer; B Doe; G R Otten; J B Ulmer
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

View more
  10 in total

Review 1.  Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.

Authors:  Elias Fattal; Gillian Barratt
Journal:  Br J Pharmacol       Date:  2009-04-02       Impact factor: 8.739

2.  High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with poly-L-lysine.

Authors:  Jeremy S Blum; W Mark Saltzman
Journal:  J Control Release       Date:  2008-04-16       Impact factor: 9.776

3.  Simultaneous release of multiple molecules from poly(lactide-co-glycolide) nanoparticles assembled onto medical devices.

Authors:  Catherine T Lo; Paul R Van Tassel; W Mark Saltzman
Journal:  Biomaterials       Date:  2009-07-09       Impact factor: 12.479

Review 4.  Innovative strategies for co-delivering antigens and CpG oligonucleotides.

Authors:  Yogita Krishnamachari; Aliasger K Salem
Journal:  Adv Drug Deliv Rev       Date:  2009-01-19       Impact factor: 15.470

Review 5.  Recent progress concerning CpG DNA and its use as a vaccine adjuvant.

Authors:  Hidekazu Shirota; Dennis M Klinman
Journal:  Expert Rev Vaccines       Date:  2013-11-26       Impact factor: 5.217

6.  Preparation and Characterization of PLGA Nanoparticles Containing Plasmid DNA Encoding Human IFN-lambda-1/IL-29.

Authors:  Parisa Amir Kalvanagh; Masoumeh Ebtekara; Parviz Kokhaei; Hoorieh Soleimanjahi
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

Review 7.  Novel approaches to vaccine delivery.

Authors:  Derek T O'Hagan; Rino Rappuoli
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

Review 8.  Pulmonary DNA vaccination: concepts, possibilities and perspectives.

Authors:  Maytal Bivas-Benita; Tom H M Ottenhoff; Hans E Junginger; Gerrit Borchard
Journal:  J Control Release       Date:  2005-09-20       Impact factor: 9.776

9.  PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium.

Authors:  Maytal Bivas-Benita; Stefan Romeijn; Hans E Junginger; Gerrit Borchard
Journal:  Eur J Pharm Biopharm       Date:  2004-07       Impact factor: 5.571

10.  Improving Single-Cell Encapsulation Efficiency and Reliability through Neutral Buoyancy of Suspension.

Authors:  Hangrui Liu; Ming Li; Yan Wang; Jim Piper; Lianmei Jiang
Journal:  Micromachines (Basel)       Date:  2020-01-15       Impact factor: 2.891

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.